Immunogenicity: Clinical Trials

1 trial for Immunogenicity, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Active not recruiting 1

Follow Immunogenicity: new trials by email Literature Review of Immunogenicity trials Research Report on Immunogenicity

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Trial to Establish Non-inferiority of Immunogenicity of a Single-dose of CERVAVAC® Quadrivalent HPV Vaccine Compared to the Gardasil® Quadrivalent Vaccine Among Girls and Boys Aged 9 to 14 Years and in Girls/Women Aged 15 to 20 Years in Zambia
quadrivalent HPV vaccine - Vaccine Effectiveness, HPV Vaccination
Phase 4Active not recruitingInternational Agency for Research on Cancer12662026-06-012026-10-05

Interventions

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (1)

Sponsors

International Agency for Research on Cancer (1)

Countries

Zambia (1)